Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Abbott Laboratories > News item |
Moody's: Abbott unchanged
Moody's Investors Service said that the National Heart, Lung and Blood Institute's decision to halt Abbott Laboratories' AIM-HIGH clinical trial before its planned end date does not have an impact on Abbott's A1/Prime-1 rating.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.